Skip to playerSkip to main content
  • 4 months ago
Chennai Pharma Firm Behind Toxic Cough Syrup Linked to Child Deaths

Category

🗞
News
Transcript
00:00The Chinay-based company behind Colriff Cuff Syrups, which have tragically killed children,
00:07is Shreesan Pharmaceuticals. And here's what we know about the company.
00:11A private firm reportedly started in 1999. It later operated as a sole proprietorship.
00:16The syrup is at the centre of a storm after 14 children in Madhya Pradesh's
00:20Chindwara district died of kidney failure following its consumption.
00:23Tamil Nadu regulators tested Colriff and found a shocking 48.6 diethylene glycol,
00:29or DEG, a toxic industrial solvent. For the unburst, the safe limit is just 0.1%.
00:35Dextromethorphan, the active ingredient in the syrup, is a common cuff suppressant
00:39that works on the brain to reduce dry cuff. Typically given as a liquid for children,
00:43it requires a solvent. While safe options like propylene glycol are used worldwide,
00:48cheaper toxic substitutes like DEG are sometimes added illegally leading to severe contamination.
00:54DEG can cause nausea, kidney failure and nerve damage.
00:57The Madhya Pradesh police have registered a case against Shreesan Pharmaceuticals.
01:01On India's largest B2B marketplace, India Mart, the company presents itself as a trader
01:06of cuff syrups, protein powders pharmaceutical syrups and herbal child growth syrups.
01:10Investigations reportedly show the GST partner behind Shreesan is listed as Ranganathan.
01:16According to media investigations, the Ministry of Corporate Affairs documents reveal that
01:20a private limited company named Shreesan Pharmaceuticals once existed with a director called Ranganathan Govindarajan.
01:26According to reports, the company incorporated in 1990 was later struck off for failing to file compliance documents.
01:33While addresses differ across records, India Mart's listings and product packaging all point to the same Chinnai neighbourhood.
01:40The Tamil Nadu government has issued a notice asking why the drug licence shouldn't be cancelled.
01:45This followed a stop production order on October 3.
01:48The tragedy has prompted precautionary bans in multiple states including Kerala and an SIT has been set up to investigate the company.
01:55The burning question remains, if the company was struck off the registrar, how was it back in the medicine business?
02:00What do you think? Let us know in the comments below.
Comments

Recommended